Annals of Surgical Oncology

, Volume 14, Issue 10, pp 2759–2765 | Cite as

Young Age Influences Treatment but not Outcome of Colon Cancer

  • H. M. Quah
  • R. Joseph
  • D. Schrag
  • J. Shia
  • J. G. Guillem
  • P. B. Paty
  • L. K. Temple
  • W. D. Wong
  • M. R. Weiser
Gastrointestinal Oncology



Early age at onset is often considered a poor prognostic factor for colon cancer. The aim of this study was to determine the association between age, clinicopathologic features, adjuvant therapy, and outcomes following colon cancer resection.


A prospective database of 1327 surgical stage I–III colon cancer patients operated on from 1990–2001 was evaluated, and patients grouped by age.


Sixty-eight patients (5%) were diagnosed at age ≤40 years (younger) compared with 1259 patients diagnosed at age >40 (older). Younger patients were more likely to have left-sided tumors (66% vs 51%, P = .02), but no more likely to present with symptomatic lesions, more advanced tumors, or have worse pathologic features. Younger patients were noted to have more nodes retrieved in their surgical specimens than older patients (median 18 vs 14, P = .001), although the numbers of total colectomies were similar in both groups. Younger patients were also more likely to receive adjuvant chemotherapy, and this was most pronounced in the stage II cohort: 39% vs 14%, P = .003. With a median follow-up of 55 months, 5-year disease-specific survival (DSS) was similar in both study groups: 86% vs 87%, but 5-year overall survival (OS) was significantly higher in the younger patient cohort (84% vs 73%, P = .001).


Younger patients undergoing complete resection of stage I–III colon cancer had DSS similar to older patients. However, younger patients had more nodes retrieved from their specimens and were more likely to receive adjuvant therapy, especially for node-negative disease. These factors may have contributed to their overall favorable outcome.


Colon carcinoma Early age Surgery Survival 


  1. 1.
    American Cancer Society. Cancer Facts, Figures 2006. Atlanta, GA: American Cancer Society; 2006Google Scholar
  2. 2.
    O’Connell JB, Maggard MA, Liu JH, Etzioni DA, Livingston EH, Ko CY. Rates of colon and rectal cancers are increasing in young adults. Am Surg 2003; 69:866–72PubMedGoogle Scholar
  3. 3.
    Lee PY, Fletcher WS, Sullivan ES, Vetto JT. Colorectal cancer in young patients: characteristics and outcome. Am Surg 1994; 60:607–12PubMedGoogle Scholar
  4. 4.
    Leff DR, Chen A, Roberts D, et al. Colorectal cancer in the young patient. Am Surg 2007; 73:42–7PubMedGoogle Scholar
  5. 5.
    Lin JT, Wang WS, Yen CC, et al. Outcome of colorectal carcinoma in patients under 40 years of age. J Gastroenterol Hepatol 2005; 20:900–5PubMedCrossRefGoogle Scholar
  6. 6.
    Minardi AJ, Jr., Sittig KM, Zibari GB, McDonald JC. Colorectal cancer in the young patient. Am Surg 1998; 64:849–53PubMedGoogle Scholar
  7. 7.
    Bedikian AY, Kantarjian H, Nelson RS, Stroehlein JR, Bodey GP. Colorectal cancer in young adults. South Med J 1981; 74:920–4PubMedGoogle Scholar
  8. 8.
    Chiang JM, Chen MC, Changchien CR, et al. Favorable influence of age on tumor characteristics of sporadic colorectal adenocarcinoma: patients 30 years of age or younger may be a distinct patient group. Dis Colon Rectum 2003; 46:904–10PubMedCrossRefGoogle Scholar
  9. 9.
    Cusack JC, Giacco GG, Cleary K, et al. Survival factors in 186 patients younger than 40 years old with colorectal adenocarcinoma. J Am Coll Surg 1996; 183:105–12PubMedGoogle Scholar
  10. 10.
    Griffin PM, Liff JM, Greenberg RS, Clark WS. Adenocarcinomas of the colon and rectum in persons under 40 years old. A population-based study. Gastroenterology 1991; 100:1033–40PubMedGoogle Scholar
  11. 11.
    Liang JT, Huang KC, Cheng AL, Jeng YM, Wu MS, Wang SM. Clinicopathological and molecular biological features of colorectal cancer in patients less than 40 years of age. Br J Surg 2003; 90:205–14PubMedCrossRefGoogle Scholar
  12. 12.
    Soliman AS, Bondy ML, Levin B, et al. Colorectal cancer in Egyptian patients under 40 years of age. Int J Cancer 1997; 71:26–30PubMedCrossRefGoogle Scholar
  13. 13.
    D’Onofrio GM, Tan EG. Is colorectal carcinoma in the young a more deadly disease? Aust N Z J Surg 1985; 55:537–40PubMedGoogle Scholar
  14. 14.
    Domergue J, Ismail M, Astre C, et al. Colorectal carcinoma in patients younger than 40 years of age. Montpellier Cancer Institute experience with 78 patients. Cancer 1988; 61:835–40PubMedCrossRefGoogle Scholar
  15. 15.
    Okuno M, Ikehara T, Nagayama M, Sakamoto K, Kato Y, Umeyama K. Colorectal carcinoma in young adults. Am J Surg 1987; 154:264–8PubMedCrossRefGoogle Scholar
  16. 16.
    Smith C, Butler JA. Colorectal cancer in patients younger than 40 years of age. Dis Colon Rectum 1989; 32:843–6PubMedCrossRefGoogle Scholar
  17. 17.
    Makela J, Kiviniemi H, Laitinen S. Prognostic factors after surgery in patients younger than 50 years old with colorectal adenocarcinoma. Hepatogastroenterology 2002; 49:971–5PubMedGoogle Scholar
  18. 18.
    Mitry E, Benhamiche AM, Jouve JL, Clinard F, Finn-Faivre C, Faivre J. Colorectal adenocarcinoma in patients under 45 years of age: comparison with older patients in a well-defined French population. Dis Colon Rectum 2001; 44:380–7PubMedCrossRefGoogle Scholar
  19. 19.
    O’Connell JB, Maggard MA, Liu JH, Etzioni DA, Livingston EH, Ko CY. Do young colon cancer patients have worse outcomes? World J Surg 2004; 28:558–62PubMedCrossRefGoogle Scholar
  20. 20.
    Paraf F, Jothy S. Colorectal cancer before the age of 40: a case-control study. Dis Colon Rectum 2000; 43:1222–6PubMedCrossRefGoogle Scholar
  21. 21.
    Turkiewicz D, Miller B, Schache D, Cohen J, Theile D. Young patients with colorectal cancer: how do they fare? ANZ J Surg 2001; 71:707–10PubMedCrossRefGoogle Scholar
  22. 22.
    Chung YF, Eu KW, Machin D, et al. Young age is not a poor prognostic marker in colorectal cancer. Br J Surg 1998; 85:1255–9PubMedCrossRefGoogle Scholar
  23. 23.
    Nelson H, Petrelli N, Carlin A, et al. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 2001; 93:583–96PubMedCrossRefGoogle Scholar
  24. 24.
    AJCC Cancer Staging Manual. 6th ed. Springer-Verlag: New York, NY; 2002Google Scholar
  25. 25.
    Bowne WB, Lee B, Wong WD, et al. Operative salvage for locoregional recurrent colon cancer after curative resection: an analysis of 100 cases. Dis Colon Rectum 2005; 48:897–909PubMedCrossRefGoogle Scholar
  26. 26.
    Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999; 116:1453–6PubMedCrossRefGoogle Scholar
  27. 27.
    Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators. J Clin Oncol 1999; 17:1356–63Google Scholar
  28. 28.
    Schrag D, Rifas-Shiman S, Saltz L, Bach PB, Begg CB. Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancer. J Clin Oncol 2002; 20:3999–4005PubMedCrossRefGoogle Scholar
  29. 29.
    NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990; 264:1444–50Google Scholar
  30. 30.
    Sarli L, Bader G, Iusco D, et al. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer. Eur J Cancer 2005; 41:272–9PubMedCrossRefGoogle Scholar
  31. 31.
    Chen SL, Bilchik AJ. More Extensive Nodal Dissection Improves Survival for Stages I to III of Colon Cancer: A Population-Based Study. Ann Surg 2006; 244:602–10PubMedGoogle Scholar
  32. 32.
    Le Voyer TE, Sigurdson ER, Hanlon AL, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol 2003; 21:2912–9PubMedCrossRefGoogle Scholar
  33. 33.
    Gryfe R, Kim H, Hsieh ET, et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 2000; 342:69–77PubMedCrossRefGoogle Scholar
  34. 34.
    Ribic CM, Sargent DJ, Moore MJ, et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 2003; 349:247–57PubMedCrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2007

Authors and Affiliations

  • H. M. Quah
    • 1
  • R. Joseph
    • 1
  • D. Schrag
    • 2
  • J. Shia
    • 3
  • J. G. Guillem
    • 1
  • P. B. Paty
    • 1
  • L. K. Temple
    • 1
  • W. D. Wong
    • 1
  • M. R. Weiser
    • 1
  1. 1.Department of SurgeryMemorial Sloan-Kettering Cancer CenterNew YorkUSA
  2. 2.Department of Medical OncologyMemorial Sloan-Kettering Cancer CenterNew YorkUSA
  3. 3.Department of PathologyMemorial Sloan-Kettering Cancer CenterNew YorkUSA

Personalised recommendations